With a market cap of has a large market cap size. Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) has been on the stock market since its IPO date on the 2/28/1996. Alexion Pharmaceuticals, Inc. is in the Biotechnology industry and Healthcare sector. Average volume for Alexion Pharmaceuticals, Inc., is 1875.75, and so far today it has a volume of 0. Performance year to date since the 2/28/1996 is -35.27%.
To help you determine whether Alexion Pharmaceuticals, Inc. is undervalued the following values will help you decide. P/E is 171.96 and forward P/E is 18.74. PEG perhaps more useful shows that Alexion Pharmaceuticals, Inc. has a value for PEG of 8.18. P/S ratio is 10.27 and the P/B ratio is 3.45. The P/Cash and P/Free cash flow is 27.04 and 52.77 respectively.
At the current price Alexion Pharmaceuticals, Inc. is trading at, 123.47 (0.00% today), Alexion Pharmaceuticals, Inc. has a dividend yield of *TBA, and this is covered by a payout ratio of 0.00%. Earnings per share (EPS) is 0.72, and this is looking to grow in the next year to 30.33% after growing -79.50% this past year. EPS growth quarter over quarter is -10.10%, and 16.80% for sales growth quarter over quarter.
The number of shares outstanding is 225.06, and the number of shares float is 223.19. The senior management bring insider ownership to 0.60%, and institutional ownership is at 98.70%. The float short is 2.13%, with the short ratio at a value of 2.53. Management has seen a return on assets of 1.10%, and also a return on investment of 1.60%.
The ability for Alexion Pharmaceuticals, Inc., to deal with debt, means it current ratio is 3.5, and quick ratio is 3. Long term debt/equity is 0.4 and total debt/equity is 0.4. In terms of margins, Alexion Pharmaceuticals, Inc. has a gross margin of 91.80%, with its operating margin at 22.10%, and Alexion Pharmaceuticals, Inc. has a profit margin of 5.40%.
The 52 week high is -40.89%, with 11.68% being its 52 week low. The 20 day simple moving average is -8.29% and the 200 day simple moving average is -19.42%.
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.